COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,553 Articles (22,400 medRxiv, 8,153 bioRxiv)

Most recent first Previous |  Page 798: Articles 7971-7980  | Next

Mobility was a Significant Determinant of Reported COVID-19 Incidence During the Omicron Surge in the Most Populous U.S. Counties
Harris, J. E.
10.1101/2022.03.16.22272523 — Posted: 2022-03-18
Protection of prior natural infection compared to mRNA vaccination against SARS-CoV-2 infection and severe COVID-19 in Qatar
Chemaitelly, H., Ayoub, H., AlMukdad, S., Coyle, P., Tang, P., YASSINE, H. M., Al-Khatib, H. A., Smatti, M. K., Hasan, M. R., Al-Kanaani, Z., Al-Kuwari, E., Jeremijenko, A., Kaleeckal, A. H., Latif, A. N., Shaik, R. M., Abdul-Rahim, H. F., Nasrallah, G., Al Kuwari, M. G., Butt, A. A., Al Romaihi, H. E., Al-Thani, M. H., Al-Khal, A., Bertollini, R., Abu-Raddad, L. J.
10.1101/2022.03.17.22272529 — Posted: 2022-03-18
A log-odds system for waning and boosting of COVID-19 vaccine effectiveness
Blakely, T., Szanyi, J., Wilson, T., Scott, N.
10.1101/2022.03.16.22272519 — Posted: 2022-03-18
Founder effect contributes to the unique pattern of SARS-CoV-2 variant B.1.1.519 emergence in Alaska
Haan, T. J., Smith, L. K., DeRonde, S., House, E., Zidek, J., Puhak, D., Redlinger, M., Parker, J., Barnes, B. M., Burkhead, J. L., Knall, C., Bortz, E., Chen, J., Drown, D. M.
10.1101/2022.03.17.22272446 — Posted: 2022-03-18
Suppression of de novo antibody responses against SARS-CoV2 and the Omicron variant after mRNA vaccination and booster in patients with B cell malignancies undergoing active treatment, but maintenance of pre-existing antibody levels against endemic viruses.
Azar, J., Evans, J. P., Sikorski, M., Chakravarthy, K., McKenney, S., Carmody, I., Zeng, C., Teodorescu, R., Song, N. J., Hamon, J., Bucci, D., Velegraki, M., Bolyard, C., Weller, K. P., Reisinger, S., Bhat, S. A., Maddocks, K. J., Gumina, R. J., Vlasova, A. N., Oltz, E. M., Saif, L. J., Chung, D., Woyach, J. A., Shields, P. G., Liu, S.-L., Li, Z., Rubinstein, M. P.
10.1101/2022.03.17.22272389 — Posted: 2022-03-18
Selection of appropriate reference genes for normalization of qRT-PCR based gene expression analysis in SARS-CoV-2, and Covid-associated Mucormycosis infection
Kumar, S., Ahmad, A., Kushwaha, N., Negi, S., Gautam, K., Singh, A., Tiwari, P., Garg, R., Agarwal, R., Mohan, A., Trikha, A., Thakar, A., Saini, V.
10.1101/2022.03.15.22272441 — Posted: 2022-03-18
Patient-reported respiratory outcome measures in the recovery of adults hospitalised with COVID-19: A systematic review and meta-analysis
Middleton, S., Chalitsios, C., McKeever, T., Jenkins, A., Bolton, C.
10.1101/2022.03.16.22272509 — Posted: 2022-03-18
Characteristics of mental health stability during COVID-19: An online survey with people residing in the Liverpool City Region
Ujhelyi Gomez, K., Corcoran, R., Ring, A., Hassan, S., Abba, K., Downing, J., Goodall, M., Gabbay, M., Clarke, P., Moran, P., Obe, D. A., Bennett, K. M.
10.1101/2022.03.17.22272479 — Posted: 2022-03-18
Effectiveness of whole virus COVID-19 vaccine at protecting health care personnel against SARS-CoV-2 infections in Lima, Peru
Arriola, C., Soto, G., Westercamp, M., Bollinger, S., Espinoza, A., Grogl, M., Llanos-Cuentas, A., Matos, E., Romero, C., Silva, M., Smith, R., Olson, N., Prouty, M., Azziz-Baumgartner, E., Lessa, F.
10.1101/2022.03.16.22271100 — Posted: 2022-03-18
COVID-19 Disease Model with Reservoir of Infection : Cleaning Surfaces and Wearing Masks Strategies
Fatiha, N., Alaoui, M. A. A., Aghriche, A., Radouane, Y.
10.1101/2022.03.16.22272508 — Posted: 2022-03-18

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).